Innovating Works

LIH

Desconocido
Mostrando 1 al 20 de 49 resultados
AIPD: AI in Parkinson s Disease In response to the growing need for specialized data scientists in healthcare, our initiative aims to establish an international, interdisci...
2024-07-08 - 2028-10-31 | Financiado
EATRIS-CONNECT: EATRIS CONNECT Since the establishment of EATRIS as an ERIC in 2014, the infrastructure has developed a growing portfolio of services and collaborative pro...
2024-06-20 - 2027-04-30 | Financiado
4M8: Formate-dependent Regulation of Cancer Metastasis LUXEMBOURG INSTITUTE OF HEALTH tramitó un HORIZON EUROPE: ERC-2023-COG Mechanisms underlying cancer metastasis are poorly understood and context dependent. An essential feature of disseminating cancer cells is m...
2024-01-18 - 2029-04-30 | Financiado
MATER: Monitoring mentAl healTh in brEast canceR LUXEMBOURG INSTITUTE OF HEALTH tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 One over three women with breast cancer will develop mental health issues, adding the burden of a deterioration of their quality of life to...
2023-06-30 - 2025-08-31 | Financiado
HealthyW8: Empowering healthy lifestyle behaviour through personalised intervention portfolios to prevent and c... LUXEMBOURG INSTITUTE OF HEALTH tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-two-stage Over 30% of EU citizens at vulnerable stages and situations in life are at increased risk to transgress from healthy weight to overweight an...
2023-05-01 - 2028-04-30 | Financiado
INCEPTOR: Investigate the mode of action ofInvestigate the mode of action of beta-carboline derivative Harmine... LUXEMBOURG INSTITUTE OF HEALTH tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 One of the major mechanisms by which solid tumors escape anti-tumor immunity is the downregulation of major histocompatibility complex class...
2023-04-20 - 2026-03-31 | Financiado
MAACS: N6 - methyladenosine RNA modification in acute coronary syndrome LUXEMBOURG INSTITUTE OF HEALTH tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 The main aim of the MAACS project is to explore if specific changes in epitranscriptomic landscape of peripheral blood mononuclear cells (PB...
2023-03-01 - 2025-02-28 | Financiado
PARC: Partnership for the Assessment of Risks from Chemicals LUXEMBOURG INSTITUTE OF HEALTH participó en un HORIZON EUROPE: HORIZON-HLTH-2021-ENVHLTH-03 PARC is an EU-wide research and innovation partnership programme to support EU and national chemical risk assessment and risk management bod...
2022-05-24 - 2029-04-30 | Financiado
4.UNCAN.eu: A Coordination and Support Action to prepare UNCAN.eu platform LUXEMBOURG INSTITUTE OF HEALTH participó en un HORIZON EUROPE: HORIZON-MISS-2021-UNCAN-01 The 15-month coordination and support action 4.UNCAN.eu will generate a strategic agenda to launch UNCAN.eu, a European initiative to UNders...
2022-05-17 - 2023-11-30 | Financiado
EVIL: Reprogramming of the leukemic microenvironment by small extracellular vesicles from characterizatio... LUXEMBOURG INSTITUTE OF HEALTH tramitó un H2020: H2020-MSCA-IF-2020 The proposed program, to be developed by Dr Pablo Morande, aims at investigating interactions between chronic lymphocytic leukemia (CLL) B-c...
2021-04-27 - 2024-04-11 | Financiado
ORCHESTRA: Connecting European Cohorts to Increase Common and Effective Response to SARS CoV 2 Pandemic ORCHES... LUXEMBOURG INSTITUTE OF HEALTH participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 The ORCHESTRA project provides an innovative approach to learn from the SARS-CoV-2 health crisis and derive recommendations for increasing p...
2020-11-06 - 2024-11-30 | Financiado
unCoVer: Unravelling Data for Rapid Evidence Based Response to COVID 19 LUXEMBOURG INSTITUTE OF HEALTH participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 UnCoVer is a functional network of research institutions collecting data derived from the provision of care to COVID-19 patients by health s...
2020-10-30 - 2023-05-14 | Financiado
COVIRNA: A diagnostic test to improve surveillance and care of COVID 19 patients LUXEMBOURG INSTITUTE OF HEALTH tramitó un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 Coronavirus disease 2019 (COVID-19) caused by infection with SARS coronavirus 2 (SARS-CoV-2) has reached pandemic proportions with more than...
2020-10-13 - 2023-04-30 | Financiado
TAILOR: Foundations of Trustworthy AI Integrating Reasoning Learning and Optimization LUXEMBOURG INSTITUTE OF HEALTH participó en un H2020: H2020-ICT-2018-20 Artificial Intelligence (AI) and all the key digital technologies that are subsumed by the term AI today are an essential part of the answer...
2020-06-11 - 2024-08-31 | Financiado
MEGAKINE: Megakines novel tools for structural insight into receptor chemokine complexes LUXEMBOURG INSTITUTE OF HEALTH tramitó un H2020: H2020-MSCA-IF-2019 Chemokines are small, secreted cytokines that activate membrane receptors belonging to the G protein-coupled receptor (GPCR) superfamily. Th...
2020-03-28 - 2023-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.